Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.

Wrona MZ, Yang Z, Zhang F, Dryhurst G.

NIDA Res Monogr. 1997;173:146-74. Review.

PMID:
9260188
3.

Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.

Escubedo E, Camarasa J, Chipana C, García-Ratés S, Pubill D.

Int Rev Neurobiol. 2009;88:121-66. doi: 10.1016/S0074-7742(09)88006-9. Review.

PMID:
19897077
4.

Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.

Cadet JL, Krasnova IN, Jayanthi S, Lyles J.

Neurotox Res. 2007 Apr;11(3-4):183-202. Review.

PMID:
17449459
5.

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI.

Pharmacol Rev. 2003 Sep;55(3):463-508. Epub 2003 Jul 17. Review.

6.

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

Clemens KJ, McGregor IS, Hunt GE, Cornish JL.

Drug Alcohol Rev. 2007 Jan;26(1):9-15. Review.

PMID:
17364831
7.

Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.

Seger D.

Clin Toxicol (Phila). 2010 Aug;48(7):695-708. doi: 10.3109/15563650.2010.516263. Review.

PMID:
20849328
8.

Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity.

Virmani A, Gaetani F, Imam S, Binienda Z, Ali S.

Ann N Y Acad Sci. 2003 May;993:197-207; discussion 287-8. Review.

PMID:
12853314
9.

Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Halpin LE, Collins SA, Yamamoto BK.

Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24. Review.

10.

The effects and consequences of selected club drugs.

Freese TE, Miotto K, Reback CJ.

J Subst Abuse Treat. 2002 Sep;23(2):151-6. Review.

PMID:
12220613
11.

Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.

Ago Y, Nakamura S, Baba A, Matsuda T.

J Pharmacol Sci. 2008 Jan;106(1):15-21. Epub 2008 Jan 16. Review.

12.
14.

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J.

Ther Drug Monit. 2004 Apr;26(2):137-44. Review.

PMID:
15228154
15.

The role of glutamate in behavioral and neurotoxic effects of methamphetamine.

Ohmori T, Abekawa T, Koyama T.

Neurochem Int. 1996 Sep;29(3):301-7. Review.

PMID:
8885289
16.

On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg.

Puerta E, Hervias I, Aguirre N.

Neuropsychobiology. 2009;60(3-4):119-29. doi: 10.1159/000253548. Epub 2009 Nov 5. Review.

17.
18.
19.

Examination of developmental neurotoxicity by the use of tissue culture model systems.

Heller A, Won L, Heller B, Hoffmann PC.

Clin Exp Pharmacol Physiol. 1995 May;22(5):375-8. Review.

PMID:
7554436
20.

Causes and consequences of methamphetamine and MDMA toxicity.

Quinton MS, Yamamoto BK.

AAPS J. 2006 May 12;8(2):E337-47. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk